<DOC>
	<DOCNO>NCT02523937</DOCNO>
	<brief_summary>The purpose study evaluate performance Soluble Fibrin assay exclusion Pulmonary Embolism Deep Venous Thrombosis . Secondary objective determine threshold value ROC curve , possible interest positive diagnosis Venous Thromboembolism ( VTE ) , verify absence influence age SF result .</brief_summary>
	<brief_title>Evaluation Soluble Fibrin Thrombosis Exclusion</brief_title>
	<detailed_description>Rationale . Pulmonary embolism ( PE ) major public health problem . D-dimer ( D-Di ) assay useful exclude VTE ( DVT PE ) specific , require irradiate expensive imaging test . Preliminary result suggest Soluble Fibrin ( SF ) assay sensitivity comparable D-Di one , high specificity thus would limit use image test . Main objective . To evaluate performance Soluble Fibrin assay term sensitivity , specificity , negative positive predictive value exclusion Pulmonary Embolism Deep Venous Thrombosis , comparison D-Dimer test . To determine threshold value ROC curve . Patients . Inclusion criterion : patient 18 year old , refer Emergency Internal Medicine Units , clinically suspect PE DVT . The study conduct compliance French regulation ethic approval , authorization process personal data ( Commission Nationale de l'Informatique et de Libert√©s , 8 , rue Vivienne CS 30223 75083 Paris Cedex 02 ) decision DR-2015-174 obtain April 2015 . A preliminary study perform April 2015 September 2015 define exclusion criterion . Comparison D-Dimer test . Plasma D-dimer ( D-Di ) soluble fibrin measure case low intermediate clinical probability . Patients classify two group , PE DVT predefined criterion accord recent guideline European Society Cardiology physician unaware SF assay result . PE DVT confirm excluded reference algorithm combine clinical probability , D-Dimer , image test three month-follow . The patient could contact three month include study take account mention `` without follow '' . SF Assays . Soluble fibrin measure one site , use prototype assay , citrate heparinized frozen plasma take baseline . Staff charge assay aware clinical diagnosis decision . Statistical Analysis result . The result D-dimer Soluble Fibrin assay exclusion PE DVT interpret basis sensitivity , specificity , negative predictive value . The ROC curve build , area curve calculate confidence interval . The suitable threshold determine curve . Then diagnosis performance SF assay calculate accord usual calculation . The patient anticoagulant treatment activation coagulation know cause include study analyze separately . Number participant require . A statistical analysis realize start study . The inclusion 50 patient positive diagnostic PE DVT 350 patient exclusion PE DVT allow calculation diagnosis performance SF assay area ROC curve accuracy 5 % . Duration study . The total duration study 12 month 18 month number patient could obtain .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Fibrin fragment D</mesh_term>
	<criteria>patient nonopposition participate evaluation , outpatient Emergency Internal Medicine Units , clinically suspect PE DVT . patient 18 year old , patient opposition participate evaluation , patient contraindication iodinate contrast medium .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Deep Venous Thrombosis</keyword>
	<keyword>Soluble Fibrin</keyword>
	<keyword>D-Dimers</keyword>
	<keyword>Low intermediate clinical probability</keyword>
</DOC>